NEU 3.32% $20.52 neuren pharmaceuticals limited

All valid points hottod, but you'd suspect that any analyst...

  1. 2,831 Posts.
    lightbulb Created with Sketch. 592
    All valid points hottod, but you'd suspect that any analyst worth their salt would be well aware of the opportunities for Acadia with NNZ-2591.

    There's even some posters on HC who have forecast how Acadia might proceed given a positive phase 2 result in the next couple of weeks.

    The only place JP has not spoken of his optimism for NNZ-2591 is from the top of Mt Everest.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.